Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Radiopharm Theranostics Ltd

RAD
Current price
0.024 AUD 0 AUD (0.00%)
Last closed 0.024 AUD
ISIN AU0000181851
Sector Healthcare
Industry Biotechnology
Exchange Australian Securities Exchange
Capitalization 54 506 587 AUD
Yield for 12 month -68.42 %
1Y
3Y
5Y
10Y
15Y
RAD
21.11.2021 - 28.11.2021

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It develops RAD 204, a programmed death-ligand 1 (PD-L1) for the treatment of non-small cell lung cancer (NSCLC); RAD 202, a human epidermal growth factor receptor 2 (HER2) to treat breast cancer and other solid tumors; and RAD 301, a diagnostic radiopharmaceutical targeting avß6 integrin in pancreatic ductal adenocarcinoma patients. The company also develops RAD 302, an avß6-integrin targeting agent for the treatment of multiple cancer types; RAD 101 and RAD 102 for brain metastases; RAD 402 to treat advanced prostate cancer; and RV01 for multiple solid tumors. The company was incorporated in 2021 and is based in Carlton, Australia. Address: 62 Lygon Street, Carlton, VIC, Australia, 3053

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.37 AUD

P/E ratio

Dividend Yield

Current Year

+1 965 107 AUD

Last Year

+293 341 AUD

Current Quarter

+300 234 AUD

Last Quarter

-1 056 908 AUD

Current Year

-19 714 891 AUD

Last Year

-3 014 271 AUD

Current Quarter

-2 964 380 AUD

Last Quarter

-4 321 521 AUD

Key Figures RAD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -32 310 221 AUD
Operating Margin TTM 771.88 %
PE Ratio
Return On Assets TTM -30.04 %
PEG Ratio
Return On Equity TTM -131.49 %
Wall Street Target Price 0.37 AUD
Revenue TTM 1 965 108 AUD
Book Value 0.061 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -4.6 %
Dividend Yield
Gross Profit TTM -13 366 441 AUD
Earnings per share -0.12 AUD
Diluted Eps TTM -0.12 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics RAD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History RAD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation RAD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 112.2088
Price Sales TTM 27.7372
Enterprise Value EBITDA 0.4209
Price Book MRQ 1.8544

Financials RAD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RAD

For 52 weeks

0.023 AUD 0.1 AUD
50 Day MA 0.028 AUD
Shares Short Prior Month
200 Day MA 0.04 AUD
Short Ratio
Shares Short
Short Percent